Skip to main content

Genetics and Pathogenesis of Distal Muscular Dystrophies

  • Chapter
  • First Online:

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 652))

Abstract

Distal myopathies are distal muscular dystrophies because they are genetic disorders with progressive loss of muscle tissue. The true distal dystrophies not only show a distal onset; they also remain more distal than proximal throughout the course of the disease. Currently almost 20 different entities of distal muscular dystrophies have been genetically determined, compared to just five entities delineated on clinical grounds in the 1980s. Half of the genes underlying these disorders have been associated with distal phenotypes only, whereas the other genes can manifest also with other than distal phenotypes such as proximal, scapuloperoneal or generalized phenotypes. Interestingly, most of the genes causing distal muscular dystrophies code for protein components of the sarcomere, in contrast to the proximal dystrophies in which most of the genes cause defects in sarcolemmal proteins. The reason for why some gene defects predominantly affect distal muscles is not well understood. The fact that the majority of these defects are due to structural and functional components of the sarcomere is intriguing but so far it does not provide further clues for understanding or for therapeutic approaches. The highly selective involvement of muscles in many of the distal dystrophies is even less well understood.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Liu J, Aoki M, Illa I, et al. Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nat Genet 1998;20:31–36.

    Article  CAS  PubMed  Google Scholar 

  2. Eisenberg I, Avidan N, Potikha T, et al. The UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy. Nat Genet 2001;29:83–87.

    Article  CAS  PubMed  Google Scholar 

  3. Hackman P, Vihola A, Haravuori H, et al. Tibial muscular dystrophy is a titinopathy caused by mutations in TTN, the gene encoding the giant skeletal-muscle protein titin. Am J Hum Genet 2002;71:492–500.

    Article  CAS  PubMed  Google Scholar 

  4. Meredith C, Herrmann R, Parry C, et al. Mutations in the slow skeletal muscle fiber myosin heavy chain gene (MYH7) cause Laing early-onset distal myopathy (MPD1). Am J Hum Genet. 2004;75:703–708.

    Article  CAS  PubMed  Google Scholar 

  5. Selcen D, Ohno K, Engel AG. Myofibrillar myopathy: clinical, morphological and genetic studies in 63 patients. Brain 2004;127:439–451.

    Article  PubMed  Google Scholar 

  6. Sjöberg G, Saavedra-Matiz C, Rosen D, et al. A missense mutation in the desmin rod domain is associated with autosomal dominant distal myopathy, and exerts a dominant negative effect on filament formation. Hum Mol Genet 1999;8:2191–2198.

    Article  PubMed  Google Scholar 

  7. Vicart P, Caron A, Guicheney P, et al. A missense mutation in the alphaB-crystallin chaperone gene causes a desmin-related myopathy. Nat Genet 1998;20:92–5.

    Article  CAS  PubMed  Google Scholar 

  8. Selcen D, Engel AG. Mutations in myotilin cause myofibrillar myopathy. Neurology 2004;62:1363–1371.

    CAS  PubMed  Google Scholar 

  9. Griggs R, Vihola A, Hackman P, et al. Zaspopathy in a large classic late onset distal myopathy family. Brain 2007;130:1477–1484.

    Google Scholar 

  10. Nishino I, Noguchi S, Murayama K, et al. Distal myopathy with rimmed vacuoles is allelic to hereditary inclusion body myopathy. Neurology 2002;59:1689–1693.

    CAS  PubMed  Google Scholar 

  11. Ahlberg G, Tell D, Borg K, et al. Genetic linkage of Welander distal myopathy to chromosome 2p13. Ann Neurol 1999;46:399–404.

    Article  CAS  PubMed  Google Scholar 

  12. Udd B, Vihola A, Sarparanta J, et al. Titinopathies and extension of the M-line mutation phenotype beyond distal myopathy and LGMD2J. Neurology 2005;64:636–642.

    CAS  PubMed  Google Scholar 

  13. de Seze J, Udd B, Haravuori H, et al. The first European tibial muscular dystrophy family outside the Finnish population. Neurology 1998;51:1746–1748.

    PubMed  Google Scholar 

  14. Van den Bergh P, Bouquiaux O, Verellen C, Marchand S, Richard I, Hackman P, Udd B. Tibial muscular dystrophy in a Belgian family. Annal Neurol 2003;54:248–251.

    Article  PubMed  Google Scholar 

  15. Hackman P, Marchand S, Sarparanta J, Vihola A, Pénisson-Besnier I, Eymard B, Pardal-Fernández J, Hammouda E, Richard I, Illa I and Udd B. Truncating mutations in C-terminal titin may cause more severe tibial muscular dystrophy (TMD). Neuromusc Disord 2008;18:922–8.

    Google Scholar 

  16. Haravuori H, Vihola A, Straub V, et al. Secondary calpain3 deficiency in 2q linked muscular dystrophy – titin is the candidate gene. Neurology 2001;56:869–877.

    CAS  PubMed  Google Scholar 

  17. Richard I, Broux O, Allamand V, et al. Mutations in the proteolytic enzyme calpain3 cause limb-girdle muscular dystrophy type 2A. Cell 1995;81:27–40.

    Article  CAS  PubMed  Google Scholar 

  18. Markesbery WR, Griggs RC, Leach RP, et al. Late onset hereditary distal –myopathy. Neurology 1974;23:127.

    Google Scholar 

  19. Selcen D, Engel AG. Mutations in ZASP define a novel form of muscular dystrophy in humans. Ann Neurol 2005;57:269–276.

    Article  CAS  PubMed  Google Scholar 

  20. Olive M, Goldfarb LG, Shatunov A, et al. Myotilinopathy: refining the clinical and myopathological phenotype. Brain 2005;128:2315–2326.

    Article  PubMed  Google Scholar 

  21. Penisson-Besnier I, Dumez C, Chateau D, et al. Autosomal dominant late adult onset distal leg myopathy. Neuromuscul Disord 1998;8:459–466.

    Article  CAS  PubMed  Google Scholar 

  22. Penisson-Besnier I, Talvinen K, Dumez C, et al. Myotilinopathy in a family with late onset myopathy. Neuromuscul Disord 2006;16:427–431.

    Article  PubMed  Google Scholar 

  23. Foroud T, Pankratz N, Batchman AP, et al. A mutation in myotilin causes spheroid body myopathy. Neurology 2005;65:1936–1940.

    Article  CAS  PubMed  Google Scholar 

  24. Milhorat AT, Wolff HG. Studies in diseases of muscle: XIII. Progressive muscular dystrophy of atrophic distal type: Report on a family: Report of autopsy. Arch Neurol Psychiatry 1943;49:655.

    Google Scholar 

  25. Walter M, Reichlich P, Hübner A, et al. Identification of a desmin gene mutation in scapuloperoneal syndrome type Kaeser. Neuromusc Disord 2006;16:708–709.

    Article  Google Scholar 

  26. Sugawara M, Kato K, Komatsu M, et al. A novel de novo mutation in the desmin gene causes desmin myopathy with toxic aggregates. Neurology 2000;55:986–990.

    CAS  PubMed  Google Scholar 

  27. Vorgerd M, van der Ven PF, Bruchertseifer V, et al. A mutation in the dimerization domain of filamin c causes a novel type of autosomal dominant myofibrillar myopathy. Am J Hum Genet 2005;77:297–304.

    Article  CAS  PubMed  Google Scholar 

  28. Tomimitsu H, Ishikawa K, Shimizu J, et al. Distal myopathy with rimmed vacuoles: novel mutations in the GNE gene. Neurology 2002;59:451–454.

    CAS  PubMed  Google Scholar 

  29. Kayashima T, Matsuo H, Satoh A, et al. Nonaka myopathy is caused by mutations in the UDP-N-acetylglucosamine-2-epimerase/N-acetylmannosamine kinase gene (GNE). J Hum Genet 2002; 47:77–79.

    Article  CAS  PubMed  Google Scholar 

  30. Nishino I, Malicdan MC, Murayama K, et al. Molecular pathomechanism of distal myopathy with rimmed vacuoles. Acta Myol 2005; 24:80–83.

    CAS  PubMed  Google Scholar 

  31. Malicdan MC, Noguchi S, Hayashi YK, et al. Prophylactic treatment with sialic acid metabolites precludes the development of the myopathic phenotype in the DMRV-hIBM mouse model. Nat Med 2009;15:690–5.

    Article  CAS  PubMed  Google Scholar 

  32. Illa I, Serrano-Munuera C, Gallardo E, et al. Distal anterior compartment myopathy: A dysferlin mutation causing a new muscular dystrophy phenotype. Ann Neurol 2001; 49:130–134.

    Article  CAS  PubMed  Google Scholar 

  33. Linssen W, de Visser M, Notermans N, et al. Genetic heterogeneity in Miyoshi type distal muscular dystrophy. Neuromusc Disord 1998;8:317–320.

    Article  CAS  PubMed  Google Scholar 

  34. Jaiswal JK, Marlow G, Summerill G, et al. Patients with a non-dysferlin Miyoshi myopathy have a novel membrane repair defect. Traffic 2006 [Epub ahead of print].

    Google Scholar 

  35. Anderson L, Davison K, Moss J, et al. Dysferlin is a plasma membrane protein and is expressed early in human development. Hum Mol Genet 1999; 8:855–861.

    Article  CAS  PubMed  Google Scholar 

  36. Matsuda C, Hayashi Y, Ogawa M, et al. The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscle. Hum Mol Genet 2001; 10:1761–1766.

    Article  CAS  PubMed  Google Scholar 

  37. Tateyama M, Aoki M, Nishino I, et al. Mutation in the caveolin-3 gene causes a peculiar form of distal myopathy. Neurology 2002; 58:323–325.

    CAS  PubMed  Google Scholar 

  38. Selcen D, Stilling G, Engel A. The earliest pathologic alterations in dysferlinopathy. Neurology 2001; 56:1472–1481.

    CAS  PubMed  Google Scholar 

  39. Bansal D, Campbell KP. Dysferlin and the plasma membrane repair in muscular dystrophy. Trends Cell Biol 2004; 14:206–213.

    Article  CAS  PubMed  Google Scholar 

  40. Laing N, Laing B, Meredith C, et al. Autosomal dominant distal myopathy: Linkage to chromosome 14. Am J Hum Genet 1995; 56:422–427.

    CAS  PubMed  Google Scholar 

  41. Voit T, Kutz P, Leube B, et al. Autosomal dominant distal myopathy: Further evidence of a chromosome 14 locus. Neuromuscul Disord 2001;11:11–19.

    Article  CAS  PubMed  Google Scholar 

  42. Zimprich F, Djamshidian A, Hainfellner J, et al. An autosomal dominant early adult onset distal muscular dystrophy. Muscle Nerve 2000;23:1876–1879.

    Article  CAS  PubMed  Google Scholar 

  43. Lamont P, Udd B, Mastaglia F, et al. Laing early-onset distal myopathy – slow myosin defect with variable abnormalities on muscle biopsy. J Neurol Neurosurg Psychiatry 2006; 77:208–215.

    Article  CAS  PubMed  Google Scholar 

  44. Wallgren-Pettersson C, Pelin K, Nowak KJ, et al. Genotype-phenotype correlations in nemaline myopathy caused by mutations in the genes for nebulin and skeletal muscle alpha-actin. Neuromuscul Disord 2004; 14:461–470.

    Article  PubMed  Google Scholar 

  45. Wallgren-Pettersson C, Lehtokari V-L, Kalimo H, et al. Distal myopathy caused by homozygous missense mutations in the nebulin gene. Brain 2007; 130:1465–1476.

    Article  PubMed  Google Scholar 

  46. Feit H, Silbergleit A, Schneider L, et al. Vocal cord and pharyngeal weakness with autosomal dominant distal myopathy: clinical description and gene localization to 5q31. Am J Hum Genet 1998; 63:1732–1742.

    Article  CAS  PubMed  Google Scholar 

  47. Senderek J, Garvey SM, Krieger M, et al. Autosomal-dominant distal myopathy associated with a recurrent missense mutation in the gene encoding the nuclear matrix protein, matrin 3. Am J Hum Genet 2009;84:511–8.

    Google Scholar 

  48. Kimonis VE, Mehta SG, Fulchiero EC, et al. Clinical studies in familial VCP myopathy associated with Paget disease of bone and frontotemporal dementia. Am J Med Genet A 2008 15;146:745–757.

    Google Scholar 

  49. Servidei S, Capon F, Spinazzola M, et al. A distinctive autosomal dominant vacuolar neuromyopathy linked to 19p13. Neurology 1999; 53:830–837.

    CAS  PubMed  Google Scholar 

  50. Di Blasi C, Moghadaszadeh B, Ciano C, et al. Abnormal lysosomal and ubiquitin-proteasome pathways in 19p13.3 distal myopathy. Ann Neurol 2004;56:133–138.

    Article  PubMed  Google Scholar 

  51. Williams DR, Reardon K, Roberts L, et al. A new dominant distal myopathy affecting posterior leg and anterior upper limb muscles. Neurology 2005; 64:1245–54.

    CAS  PubMed  Google Scholar 

  52. Mahjneh I, Haravuori H, Paetau A, et al. A distinct phenotype of distal myopathy in a large Finnish family. Neurology 2003; 61:87–92.

    CAS  PubMed  Google Scholar 

  53. Haravuori H, Siitonen A, Mahjneh I, et al. Linkage to two separate loci in a family with a novel distal myopathy phenotype (MPD3). Neuromusc Disord 2004; 14:183–187.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bjarne Udd .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science+Business Media B.V.

About this chapter

Cite this chapter

Udd, B. (2009). Genetics and Pathogenesis of Distal Muscular Dystrophies. In: Espinós, C., Felipo, V., Palau, F. (eds) Inherited Neuromuscular Diseases. Advances in Experimental Medicine and Biology, vol 652. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-2813-6_3

Download citation

Publish with us

Policies and ethics